Table 3 Rearrangements identified in our series

From: Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma

Case #

Gene 1

Gene 2

Site 1 description

Site 2 description

Fusion

FGFR2 fusions

 #11

FGFR2

CEP55

Exon 17 of FGFR2

Exon 2 of CEP55

Protein fusion: in frame (FGFR2-CEP55)

 #12

FGFR2

SASS6

Intron of FGFR2(−): 80 bp after exon 16

Intron of SASS6(−): 586 bp before exon 7

Protein fusion: in frame (FGFR2-SASS6)

 #14

FGFR2

DISP1

Intron of FGFR2(−): 276 bp before exon 17

Intron of DISP1(+): 9Kb after exon 2

Protein fusion: out of frame (DISP1-FGFR2)

 #14

FGFR2

TXLNA

Intron of FGFR2(−): 687 bp before exon 17

Intron of TXLNA(+): 1kb before exon 5

Protein fusion: in frame (FGFR2-TXLNA)

 #15

VCL

FGFR2

Exon 13 of VCL(+)

Intron of FGFR2(−):

535 bp before exon 17

Protein fusion: mid-exon (FGFR2-VCL)

ALK fusion a

     

 #18

STRN

ALK

Exon 3 of STRN (NM-003162)

Exon 20 of ALK (NM-004304)

Protein fusion: in frame (STRN-ALK)

  1. aIdentified in the primary and recurrent pancreatic tumors as well as in the celiac lymph node metastasis